Статья

A dissection of SARS-CoV2 with clinical implications (Review)

F. Stancioiu, G. Papadakis, S. Kteniadakis, B. Izotov, M. Coleman, D. Spandidos, A. Tsatsakis,
2021

We are being confronted with the most consequential pandemic since the Spanish flu of 1918-1920 to the extent that never before have 4 billion people quarantined simultaneously; to address this global challenge we bring to the forefront the options for medical treatment and summarize SARS-CoV2 structure and functions, immune responses and known treatments. Based on literature and our own experience we propose new interventions, including the use of amiodarone, simvastatin, pioglitazone and curcumin. In mild infections (sore throat, cough) we advocate prompt local treatment for the naso-pharynx (inhalations; aerosols; nebulizers); for moderate to severe infections we propose a tried-and-true treatment: the combination of arginine and ascorbate, administered orally or intravenously. The material is organized in three sections: i) Clinical aspects of COVID-19; acute respiratory distress syndrome (ARDS); known treatments; ii) Structure and functions of SARS-CoV2 and proposed antiviral drugs; iii) The combination of arginine-ascorbate. © 2020 Spandidos Publications. All rights reserved.

Цитирование

Похожие публикации

Источник

Версии

  • 1. Version of Record от 2021-04-27

Метаданные

Об авторах
  • F. Stancioiu
    Bio-Forum Foundation, Bucharest, 030121, Romania
  • G. Papadakis
    Department of Radiology, Medical School, University of Crete, Heraklion, 71003, Greece
  • S. Kteniadakis
    Emergency Department, Venizeleion General Hospital, Heraklion, 71409, Greece
  • B. Izotov
    Department of Analytical and Forensic Medical Toxicology, Sechenov University, Moscow, 119991, Russian Federation
  • M. Coleman
    School of Life and Health Sciences, Aston University, Birmingham, B4 7ET, United Kingdom
  • D. Spandidos
    Laboratory of Clinical Virology, Medical School, University of Crete, Heraklion, 71003, Greece
  • A. Tsatsakis
    Department of Forensic Sciences and Toxicology, Faculty of Medicine, University of Crete, Heraklion, 71003, Greece
Название журнала
  • International Journal of Molecular Medicine
Том
  • 46
Выпуск
  • 2
Страницы
  • 489-508
Ключевые слова
  • adalimumab; alpha interferon; amiodarone; antivirus agent; arginine; ascorbic acid; C reactive protein; chloroquine; chlorpromazine; curcumin; cyclosporine; etanercept; hydroxymethylglutaryl coenzyme A reductase inhibitor; hypertensive factor; infliximab; lactate dehydrogenase; loperamide; lopinavir; methylprednisolone; mycophenolic acid; pioglitazone; remdesivir; ritonavir; rituximab; rosuvastatin; simvastatin; troponin; tumor necrosis factor; unindexed drug; ustekinumab; adult respiratory distress syndrome; aging; cardiovascular disease; case fatality rate; clinical feature; coronavirus disease 2019; coughing; diabetes mellitus; early intervention; fever; genetic association; human; hypertension; hypotension; infection prevention; nonhuman; pH; priority journal; Review; risk assessment; Severe acute respiratory syndrome coronavirus 2; sore throat
Издатель
  • Spandidos Publications
Тип документа
  • Review
Тип лицензии Creative Commons
  • CC
Правовой статус документа
  • Свободная лицензия
Источник
  • scopus